Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Cervical Cancer in Morocco: Epidemiological Profile from Two Main Oncological Centers

  • Berraho, Mohamed (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine) ;
  • Bendahhou, Karima (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine) ;
  • Obtel, Majdouline (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine) ;
  • Zidouh, Ahmed (Lalla Salma Association Against Cancer (ALSC)) ;
  • Benider, Abdellatif (Oncology Department, Ibn Rochd University Hospital Center) ;
  • Errihani, Hassan (National Institute of Oncology (INO)) ;
  • Nejjari, Chakib (Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: In Morocco, the epidemiological profile of cervical cancer is not well established. The focus of the present study was both epidemiological and pathological characteristics. Methods: For all cases of cervical cancer treated between 2003 and 2007 in the National Institute of Oncology and the Oncology Department of the IbnRochd hospital (Casablanca), 900 cases were randomly selected. Results: The mean age was $52.1{\pm}11.8$ years. The most (90.5%) represented histological type was squamous cell carcinoma. For more than 57.0% cases the mean distance between patient's origin and center of treatment was greater than 100km. According to the FIGO classification, only 17.2% of patients were identified as being in early stages (0 and I). For 72.2% patients the follow-up did not exceed 2 years. At 1 year of following-up 55.8% of patients were alive and 43.4% were lost to following-up. Conclusion: Our study addressed the issue of the burden of cervical cancer in Morocco. The result provides a basis for decision-makers for the development of strategic measures to implement the fight against cervical cancer in Morocco.

Keywords

References

  1. Barillot I, Horiot JC, Pigneux J, et al (1997). Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys, 38, 969-78. https://doi.org/10.1016/S0360-3016(97)00145-4
  2. Bergeron C, Cartier I, Guldner L, et al (2005). Lesions precancereuses et cancers du col de l'uterus diagnostiques par le frottis cervical. Ile-de-France, enquete Crisap, 2002. Bull Epidemiol Hebd, 2, 5-6.
  3. Boo YK, Kim WC, Lee HY, et al (2011). Incidence Trends in Invasive Uterine Cervix Cancer and Carcinoma in Situ in Incheon, South Korea. Asian Pac J Cancer Prev, 12, 1985-8.
  4. Dalmon C, Guillot E, Rodrigues A, et al (2009). Access to preventative care, screening and treatment of women in vulnerable socio-economic groups presenting with cervical cancer. Bull Cancer, 96, 961-9.
  5. Fagundes H, Perez CA, Grigsby PW, Lockett MA (1992). Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 24, 197-204.
  6. Ferlay J, Shin H, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  7. Fyles AW, Pintilie M, Kirkbride P, et al (1995). Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol, 35, 107-17. https://doi.org/10.1016/0167-8140(95)01535-O
  8. Gien LT, Beauchemin MC, Thomas G, Adenocarcinoma (2010). A unique cervical cancer. Gynecol Oncol, 116, 140-6. https://doi.org/10.1016/j.ygyno.2009.09.040
  9. Gueddari M (2001). Diagnostic precoce des cancers du sein et du col uterin. Ministere de la Sante, direction de l'epidemiologie et de lutte contre les maladies, Rabat.
  10. Hakama M (1985). Evaluation of screening programmes for gynaecological cancer. Br J Cancer, 52, 669-73. https://doi.org/10.1038/bjc.1985.241
  11. International Agency for Research on Cancer (IARC) (2008). Handbooks of Cancer Prevention (2008). Volume 10: Cervix cancer screening.
  12. International Agency for Research on Cancer (IARC) (2008). World cancer report.
  13. Jacqueme B, Coudert C, Mabriez JC, Bonnier P, Piana L (2002). Antecedents de depistage cytologique chez les patientes traitees pour cancer infiltrant du col de l'uterus. Bull Cancer, 89, 234-40.
  14. Karimi Zarchi M, Akhavan A, Fallahzadeh H, et al (2010). Outcome of Cervical Cancer in Iranian Patients According to Tumor Histology, Stage of Disease and Therapy. APJCP, 11, 1289-91.
  15. Khan MJ, Partridge EE, Wang SS, Schiffman M (2005). Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer, 104, 61-70. https://doi.org/10.1002/cncr.21129
  16. Lankoande J, Sakande B, Ouedraogo A, et al (1998). Le cancer du col uterin: aspects epidemiocliniques et anatomopathologiques. Med Afr Noire, 45, 442-5.
  17. Mignotte H, Perol D, Fontaniere B, et al (1999). Le depistage de masse du cancer du col uterin peut-il atteindre une population a risque? Resultats d'un programme pilote de depistage de masse du cancer du col uterin dans trois communes de l'agglomeration lyonnaise. Bull Cancer, 86, 573-9.
  18. Miller BA, Kolonel LN, Bernstein L, et al (1996). Racial/Ethnic Patterns of Cancer in the United States 1988-1992, National Cancer Institute. NIH Pub.
  19. Missaoui N, Hmissa S, Trabelsi A, et al (2010). Cervix Cancer in Tunisia: Clinical and Pathological Study. Asian Pac J Cancer Prev, 11, 235-8.
  20. National Cancer Institute USA (2009). SEER Cancer Statistics Review, 1975-2009. http://seer.cancer.gov/csr/1975_2009_pops09/index.html
  21. Parikh S, Brennan P, Boffetta P (2003). Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer, 105, 687-91. https://doi.org/10.1002/ijc.11141
  22. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  23. Perez CA, Grigsby PW, Nene SM, et al (1992). Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer, 69, 2796-806. https://doi.org/10.1002/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O
  24. Perez CA, Hoskins WJ, Yung RC, (1997). Principles and Practice of Gynecological Oncology. Philadelphia, J.B. Lippincott Company.
  25. Pignon T, Ratovonarivo H, Rafaramino F, Ruggieri S (1993). La curietherapie dans le traitement des cancers du col uterin a Madagascar. Bull Cancer Radiother, 80, 118-24.
  26. Ponten J, Adami HO, Bergstrom R, et al (1995). Strategies for global control of cervical cancer. Int J Cancer, 60, 1-26. https://doi.org/10.1002/ijc.2910600102
  27. Remontet L, Esteve J, Bouvier AM, et al (2003a). Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique, 51, 3-30.
  28. Remontet L, Buemi A, Velten M, Jougla E, Esteve J (2003b). Evolution de l'incidence et de la mortalite par cancer en France de 1978 a 2000. Publie par les Registres des cancers francais (Francim), l'Institut de veille sanitaire et l'Inserm Paris. Actis.
  29. Resbeut M, Fondrinier E, Fervers B, et al (2003). Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic). Bull Cancer, 90, 333-46.
  30. Sankaranarayanan R, Budukh AM, Rajkumar R (2001). Effective screening programmes for cervical cancer in low - and middle-income developing countries. Bull World Health Organ, 79, 954-62.
  31. Smith HO, Tiffany MF, Qualls CR, Key CR (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol, 78, 97-105. https://doi.org/10.1006/gyno.2000.5826
  32. Sparen P, Gustafsson L, Friberg LG, et al (1995). Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment. J Clin Oncol, 13, 715-25.
  33. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44. https://doi.org/10.1002/cncr.20064

Cited by

  1. Understanding and Responsiveness Level about Cervical Cancer and its Avoidance among Young Women of Pakistan vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4877
  2. Update knowledge on cervical cancer incidence and prevalence in Asia vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3617
  3. Socio-Demographic, Reproductive and Clinical Profile of Women Diagnosed with Advanced Cervical Cancer in a Tertiary Care Institute of Delhi vol.67, pp.1, 2017, https://doi.org/10.1007/s13224-016-0907-x